- Home
- HUT vs HRMY Comparison
HUT vs HRMY Comparison
Compare HUT & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUT
- HRMY
- Stock Information
- Founded
- HUT 2011
- HRMY 2017
- Country
- HUT United States
- HRMY United States
- Employees
- HUT N/A
- HRMY N/A
- Industry
- HUT Finance: Consumer Services
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- HUT Finance
- HRMY Health Care
- Exchange
- HUT Nasdaq
- HRMY Nasdaq
- Market Cap
- HUT 1.8B
- HRMY 1.9B
- IPO Year
- HUT N/A
- HRMY 2020
- Fundamental
- Price
- HUT $23.48
- HRMY $33.23
- Analyst Decision
- HUT Strong Buy
- HRMY Buy
- Analyst Count
- HUT 5
- HRMY 9
- Target Price
- HUT $32.60
- HRMY $47.00
- AVG Volume (30 Days)
- HUT 8.1M
- HRMY 1.2M
- Earning Date
- HUT 11-13-2024
- HRMY 10-29-2024
- Dividend Yield
- HUT N/A
- HRMY N/A
- EPS Growth
- HUT N/A
- HRMY N/A
- EPS
- HUT 1.91
- HRMY 2.11
- Revenue
- HUT $194,021,000.00
- HRMY $681,879,000.00
- Revenue This Year
- HUT $40.09
- HRMY $24.63
- Revenue Next Year
- HUT $36.67
- HRMY $18.04
- P/E Ratio
- HUT $12.27
- HRMY $15.69
- Revenue Growth
- HUT 209.07
- HRMY 25.83
- 52 Week Low
- HUT $6.18
- HRMY $28.14
- 52 Week High
- HUT $28.47
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- HUT 63.95
- HRMY 45.24
- Support Level
- HUT $23.67
- HRMY $32.35
- Resistance Level
- HUT $26.49
- HRMY $33.66
- Average True Range (ATR)
- HUT 2.32
- HRMY 1.20
- MACD
- HUT 0.20
- HRMY -0.12
- Stochastic Oscillator
- HUT 62.57
- HRMY 20.69
About HUT Hut 8 Corp.
Hut 8 Corp is engaged in the mining of digital assets with an operational focus on utilizing specialized equipment to solve complex computational problems to validate transactions on the Bitcoin blockchain and receiving Bitcoin in return for successful services. The company has four reportable business segments: Digital Assets Mining, Managed Services, High Performance Computing -Colocation and Cloud, and Other. It derives maximum revenue from Digital Assets Mining segment.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.